FangDD Announces Pricing of US$5.0 Million Registered Direct Offering
October 04, 2024 14:20 ET
|
Fangdd Network Group Ltd
SHENZHEN, China, Oct. 04, 2024 (GLOBE NEWSWIRE) -- Fangdd Network Group Ltd. (Nasdaq: DUO) (“FangDD” or the “Company”), a customer-oriented property technology company in China, today announced that...
Métaux Genius clôture un placement privé d’un montant total de 757 000 $
October 04, 2024 12:53 ET
|
Métaux Genius Inc.
MONTRÉAL, 04 oct. 2024 (GLOBE NEWSWIRE) -- Métaux Genius Inc. (TSXV: GENI) (« Métaux Genius » ou la « Société ») a le plaisir d'annoncer la clôture d’un placement privé sans courtier...
Genius Metals Closes Private Placement for a total amount of $757,000
October 04, 2024 12:53 ET
|
Genius Metals Inc.
Genius Metals announce the closing of a non-brokered private placement previously announced on September 24, 2024, raising total gross proceeds of $757,000
Apollo Silver Announces Upsizing of Private Placement
October 04, 2024 10:04 ET
|
Apollo Silver Corp.
VANCOUVER, British Columbia, Oct. 04, 2024 (GLOBE NEWSWIRE) -- Apollo Silver Corp. (“Apollo Silver” or the “Company”) (TSX.V:APGO, OTCQB:APGOF, Frankfurt:6ZF0) is pleased to announce that due to...
Rocky Mountain Chocolate Factory Enters Into New $6 Million Credit Facility
October 04, 2024 08:30 ET
|
Rocky Mountain Chocolate Factory, Inc.
DURANGO, Colo., Oct. 04, 2024 (GLOBE NEWSWIRE) -- Rocky Mountain Chocolate Factory Inc. (Nasdaq: RMCF) (the “Company”, “we”, or “RMCF”), an international franchisor and producer of premium...
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
October 04, 2024 08:01 ET
|
Taysha Gene Therapies, Inc.
DALLAS, Oct. 04, 2024 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies...
Humacyte Announces Pricing of $30.0 Million Registered Direct Offering
October 04, 2024 08:00 ET
|
Humacyte, Inc
DURHAM, N.C., Oct. 04, 2024 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at...
Lifecore Biomedical Raises $24.3 Million in Private Placement of Common Stock
October 04, 2024 07:20 ET
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Oct. 04, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced the closing...
Global mRNA Cancer Vaccine Clinical Trial FDA Approval Market Size Future Opportunity Companies Insight
October 04, 2024 06:55 ET
|
KuicK Research
Delhi, Oct. 04, 2024 (GLOBE NEWSWIRE) -- Global mRNA Cancer Vaccines Clinical Trials and Market Future Outlook 2024 Report Highlights: mRNA Cancer Vaccines In Clinical Trials: > 60...
VERYPAY permet d’accélérer l’inclusion financière de millions d’Africains
October 04, 2024 06:40 ET
|
VERYPAY
LONDRES, 04 oct. 2024 (GLOBE NEWSWIRE) -- VERYPAY a dévoilé, ce jour, ses plans ambitieux consistant à favoriser l’inclusion financière de millions d’Africains mal desservis au cours de la prochaine...